1
|
Ng WJ, Wong FC, Abd Manan F, Chow YL, Ooi AL, Ong MK, Zhang X, Chai TT. Antioxidant Peptides and Protein Hydrolysates from Tilapia: Cellular and In Vivo Evidences for Human Health Benefits. Foods 2024; 13:2945. [PMID: 39335873 PMCID: PMC11431209 DOI: 10.3390/foods13182945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Revised: 09/06/2024] [Accepted: 09/12/2024] [Indexed: 09/30/2024] Open
Abstract
Antioxidant peptides derived from aquatic organisms have attracted tremendous research interest due to their potential applications in human health. Tilapia is one of the most widely farmed aquaculture species globally. The current understanding of tilapia-derived antioxidant peptides is gradually expanding. This review discusses the current knowledge of peptides and protein hydrolysates derived from tilapia muscle, skin, and scales, whose antioxidant capacity has been validated in various cellular and in vivo models. To date, at least 16 peptides and several hydrolysates have been identified from tilapia that protect human and non-human cell models against oxidative injury. Tilapia hydrolysates and peptide mixtures have also shown protective effects in animal models of oxidative stress-associated diseases and exercise-induced oxidative injury and fatigue. The key mechanisms of tilapia hydrolysates and peptide mixtures involve enhancing antioxidant enzyme activities and suppressing radical production. Notably, such hydrolysates also exerted additional in vivo functions, such as anti-inflammatory, anti-diabetic, wound healing, and antiaging properties. Taken together, tilapia-derived antioxidant peptides and hydrolysates represent a valuable source of functional ingredients for applications in functional food, dietary supplements, and therapeutic applications. Continued research into their health benefits is warranted in the future.
Collapse
Affiliation(s)
- Wen-Jie Ng
- Department of Allied Health Sciences, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia;
- Centre for Biomedical and Nutrition Research, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia
| | - Fai-Chu Wong
- Department of Chemical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia;
- Center for Agriculture and Food Research, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; (Y.-L.C.); (A.-L.O.); (M.-K.O.)
| | - Fazilah Abd Manan
- Department of Biosciences, Faculty of Science, Universiti Teknologi Malaysia, Skudai 81310, Malaysia;
| | - Yit-Lai Chow
- Center for Agriculture and Food Research, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; (Y.-L.C.); (A.-L.O.); (M.-K.O.)
- Department of Biological Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia
| | - Ai-Lin Ooi
- Center for Agriculture and Food Research, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; (Y.-L.C.); (A.-L.O.); (M.-K.O.)
- Department of Agricultural and Food Science, Faculty of Science, Universiti Tunku Abdul Rahman, Jalan Universiti, Bandar Barat, Kampar 31900, Malaysia
| | - Mei-Kying Ong
- Center for Agriculture and Food Research, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; (Y.-L.C.); (A.-L.O.); (M.-K.O.)
- Department of Agricultural and Food Science, Faculty of Science, Universiti Tunku Abdul Rahman, Jalan Universiti, Bandar Barat, Kampar 31900, Malaysia
| | - Xuewu Zhang
- College of Food Science and Engineering, South China University of Technology, 381 Wushan Road, Guangzhou 510640, China;
- Era Biotechnology (Shenzhen) Co., Ltd., Shenzhen 518115, China
| | - Tsun-Thai Chai
- Department of Chemical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia;
- Center for Agriculture and Food Research, Universiti Tunku Abdul Rahman, Kampar 31900, Malaysia; (Y.-L.C.); (A.-L.O.); (M.-K.O.)
| |
Collapse
|
2
|
Rosendahl J, Zarna C, Håkansson J, Chinga-Carrasco G. Gene-Expression Analysis of Human Fibroblasts Affected by 3D-Printed Carboxylated Nanocellulose Constructs. BIOENGINEERING (BASEL, SWITZERLAND) 2023; 10:bioengineering10010121. [PMID: 36671693 PMCID: PMC9854960 DOI: 10.3390/bioengineering10010121] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 01/12/2023] [Accepted: 01/13/2023] [Indexed: 01/18/2023]
Abstract
Three-dimensional (3D) printing has emerged as a highly valuable tool to manufacture porous constructs. This has major advantages in, for example, tissue engineering, in which 3D scaffolds provide a microenvironment with adequate porosity for cell growth and migration as a simulation of tissue regeneration. In this study, we assessed the suitability of three cellulose nanofibrils (CNF) that were obtained through 2,2,6,6-tetramethylpyperidine-1-oxyl (TEMPO)-mediated oxidation. The CNFs were obtained by applying three levels of carboxylation, i.e., 2.5, 3.8, and 6.0 mmol sodium hypochlorite (NaClO) per gram of cellulose. The CNFs exhibited different nanofibrillation levels, affecting the corresponding viscosity and 3D printability of the CNF gels (0.6 wt%). The scaffolds were manufactured by micro-extrusion and the nanomechanical properties were assessed with nanoindentation. Importantly, fibroblasts were grown on the scaffolds and the expression levels of the marker genes, which are relevant for wound healing and proliferation, were assessed in order to reveal the effect of the 3D-scaffold microenvironment of the cells.
Collapse
Affiliation(s)
- Jennifer Rosendahl
- Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, P.O. Box 857, SE-50115 Borås, Sweden
| | - Chiara Zarna
- RISE PFI, Høgskoleringen 6b, 7491 Trondheim, Norway
| | - Joakim Håkansson
- Unit of Biological Function, Division Materials and Production, RISE Research Institutes of Sweden, P.O. Box 857, SE-50115 Borås, Sweden
- Department of Laboratory Medicine, Institute of Biomedicine, Gothenburg University, P.O. Box 440, SE-40530 Gothenburg, Sweden
| | | |
Collapse
|
3
|
Emre Oz Y, Keskin-Erdogan Z, Safa N, Esin Hames Tuna E. A review of functionalised bacterial cellulose for targeted biomedical fields. J Biomater Appl 2021; 36:648-681. [PMID: 33673762 DOI: 10.1177/0885328221998033] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Bacterial cellulose (BC), which can be produced by microorganisms, is an ideal biomaterial especially for tissue engineering and drug delivery systems thanks to its properties of high purity, biocompatibility, high mechanical strength, high crystallinity, 3 D nanofiber structure, porosity and high-water holding capacity. Therefore, wide ranges of researches have been done on the BC production process and its structural and physical modifications to make it more suitable for certain targeted biomedical applications thoroughly. BC's properties such as mechanical strength, pore diameter and porosity can be tuned in situ or ex situ processes by using various polymer and compounds. Besides, different organic or inorganic compounds that support cell attachment, proliferation and differentiation or provide functions such as antimicrobial effectiveness can be gained to its structure for targeted application. These processes not only increase the usage options of BC but also provide success for mimicking the natural tissue microenvironment, especially in tissue engineering applications. In this review article, the studies on optimisation of BC production in the last decade and the BC modification and functionalisation studies conducted for the three main perspectives as tissue engineering, drug delivery and wound dressing with diverse approaches are summarized.
Collapse
Affiliation(s)
- Yunus Emre Oz
- Department of Bioengineering, Graduate School of Natural and Applied Science, Ege University, Izmir, Turkey
| | - Zalike Keskin-Erdogan
- Division of Biomaterials and Tissue Engineering, Eastman Dental Institute, University College London, London, UK
| | - Neriman Safa
- Department of Bioengineering, Graduate School of Natural and Applied Science, Ege University, Izmir, Turkey
| | - E Esin Hames Tuna
- Department of Bioengineering, Graduate School of Natural and Applied Science, Ege University, Izmir, Turkey.,Department of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey
| |
Collapse
|
4
|
Portela R, Leal CR, Almeida PL, Sobral RG. Bacterial cellulose: a versatile biopolymer for wound dressing applications. Microb Biotechnol 2019; 12:586-610. [PMID: 30838788 PMCID: PMC6559198 DOI: 10.1111/1751-7915.13392] [Citation(s) in RCA: 221] [Impact Index Per Article: 44.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2018] [Revised: 02/11/2019] [Accepted: 02/12/2019] [Indexed: 12/11/2022] Open
Abstract
Although several therapeutic approaches are available for wound and burn treatment and much progress has been made in this area, room for improvement still exists, driven by the urgent need of better strategies to accelerate wound healing and recovery, mostly for cases of severe burned patients. Bacterial cellulose (BC) is a biopolymer produced by bacteria with several advantages over vegetal cellulose, such as purity, high porosity, permeability to liquid and gases, elevated water uptake capacity and mechanical robustness. Besides its biocompatibility, BC can be modified in order to acquire antibacterial response and possible local drug delivery features. Due to its intrinsic versatility, BC is the perfect example of a biotechnological response to a clinical problem. In this review, we assess the BC main features and emphasis is given to a specific biomedical application: wound dressings. The production process and the physical-chemical properties that entitle this material to be used as wound dressing namely for burn healing are highlighted. An overview of the most common BC composites and their enhanced properties, in particular physical and biological, is provided, including the different production processes. A particular focus is given to the biochemistry and genetic manipulation of BC. A summary of the current marketed BC-based wound dressing products is presented, and finally, future perspectives for the usage of BC as wound dressing are foreseen.
Collapse
Affiliation(s)
- Raquel Portela
- Laboratory of Molecular Microbiology of Bacterial PathogensUCIBIO@REQUIMTEDepartamento de Ciências da VidaFaculdade de Ciências e TecnologiaUniversidade Nova de Lisboa2829‐516CaparicaPortugal
| | - Catarina R. Leal
- Área Departamental de FísicaISEL ‐ Instituto Superior de Engenharia de LisboaInstituto Politécnico de LisboaRua Conselheiro Emídio Navarro 1P‐1959‐007LisboaPortugal
- CENIMAT/I3NDepartamento de Ciência dos MateriaisFaculdade Ciências e TecnologiaUniversidade Nova de Lisboa2829‐516CaparicaPortugal
| | - Pedro L. Almeida
- Área Departamental de FísicaISEL ‐ Instituto Superior de Engenharia de LisboaInstituto Politécnico de LisboaRua Conselheiro Emídio Navarro 1P‐1959‐007LisboaPortugal
- CENIMAT/I3NDepartamento de Ciência dos MateriaisFaculdade Ciências e TecnologiaUniversidade Nova de Lisboa2829‐516CaparicaPortugal
| | - Rita G. Sobral
- Laboratory of Molecular Microbiology of Bacterial PathogensUCIBIO@REQUIMTEDepartamento de Ciências da VidaFaculdade de Ciências e TecnologiaUniversidade Nova de Lisboa2829‐516CaparicaPortugal
| |
Collapse
|
5
|
Afewerki S, Sheikhi A, Kannan S, Ahadian S, Khademhosseini A. Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: Towards natural therapeutics. Bioeng Transl Med 2019; 4:96-115. [PMID: 30680322 PMCID: PMC6336672 DOI: 10.1002/btm2.10124] [Citation(s) in RCA: 204] [Impact Index Per Article: 40.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2018] [Revised: 11/23/2018] [Accepted: 11/26/2018] [Indexed: 12/12/2022] Open
Abstract
Gelatin is a promising material as scaffold with therapeutic and regenerative characteristics due to its chemical similarities to the extracellular matrix (ECM) in the native tissues, biocompatibility, biodegradability, low antigenicity, cost-effectiveness, abundance, and accessible functional groups that allow facile chemical modifications with other biomaterials or biomolecules. Despite the advantages of gelatin, poor mechanical properties, sensitivity to enzymatic degradation, high viscosity, and reduced solubility in concentrated aqueous media have limited its applications and encouraged the development of gelatin-based composite hydrogels. The drawbacks of gelatin may be surmounted by synergistically combining it with a wide range of polysaccharides. The addition of polysaccharides to gelatin is advantageous in mimicking the ECM, which largely contains proteoglycans or glycoproteins. Moreover, gelatin-polysaccharide biomaterials benefit from mechanical resilience, high stability, low thermal expansion, improved hydrophilicity, biocompatibility, antimicrobial and anti-inflammatory properties, and wound healing potential. Here, we discuss how combining gelatin and polysaccharides provides a promising approach for developing superior therapeutic biomaterials. We review gelatin-polysaccharides scaffolds and their applications in cell culture and tissue engineering, providing an outlook for the future of this family of biomaterials as advanced natural therapeutics.
Collapse
Affiliation(s)
- Samson Afewerki
- Biomaterials Innovation Research Center, Division of Biomedical Engineering, Dept. of MedicineBrigham and Women's Hospital, Harvard Medical SchoolCambridgeMA 02142
- Harvard‐MIT Division of Health Sciences and TechnologyMassachusetts Institute of TechnologyCambridgeMA 02139
| | - Amir Sheikhi
- Biomaterials Innovation Research Center, Division of Biomedical Engineering, Dept. of MedicineBrigham and Women's Hospital, Harvard Medical SchoolCambridgeMA 02142
- Harvard‐MIT Division of Health Sciences and TechnologyMassachusetts Institute of TechnologyCambridgeMA 02139
- Center for Minimally Invasive Therapeutics (C‐MIT)University of California‐Los AngelesLos AngelesCA 90095
- California NanoSystems Institute (CNSI)University of California‐Los AngelesLos AngelesCA 90095
- Dept. of BioengineeringUniversity of California‐Los AngelesLos AngelesCA 90095
| | - Soundarapandian Kannan
- Biomaterials Innovation Research Center, Division of Biomedical Engineering, Dept. of MedicineBrigham and Women's Hospital, Harvard Medical SchoolCambridgeMA 02142
- Harvard‐MIT Division of Health Sciences and TechnologyMassachusetts Institute of TechnologyCambridgeMA 02139
- Nanomedicine Division, Dept. of ZoologyPeriyar UniversitySalemTamil NaduIndia
| | - Samad Ahadian
- Center for Minimally Invasive Therapeutics (C‐MIT)University of California‐Los AngelesLos AngelesCA 90095
- California NanoSystems Institute (CNSI)University of California‐Los AngelesLos AngelesCA 90095
- Dept. of BioengineeringUniversity of California‐Los AngelesLos AngelesCA 90095
| | - Ali Khademhosseini
- Biomaterials Innovation Research Center, Division of Biomedical Engineering, Dept. of MedicineBrigham and Women's Hospital, Harvard Medical SchoolCambridgeMA 02142
- Harvard‐MIT Division of Health Sciences and TechnologyMassachusetts Institute of TechnologyCambridgeMA 02139
- Center for Minimally Invasive Therapeutics (C‐MIT)University of California‐Los AngelesLos AngelesCA 90095
- California NanoSystems Institute (CNSI)University of California‐Los AngelesLos AngelesCA 90095
- Dept. of BioengineeringUniversity of California‐Los AngelesLos AngelesCA 90095
- Dept. of Radiological Sciences, David Geffen School of MedicineUniversity of California‐Los AngelesLos AngelesCA 90095
- Dept. of Chemical and Biomolecular EngineeringUniversity of California‐Los AngelesLos AngelesCA 90095
- Dept. of Bioindustrial Technologies, College of Animal Bioscience and TechnologyKonkuk UniversitySeoulRepublic of Korea
| |
Collapse
|
6
|
Hsiao HL, Lin SB, Chen LC, Chen HH. Hurdle Effect of Antimicrobial Activity Achieved by Time Differential Releasing of Nisin and Chitosan Hydrolysates from Bacterial Cellulose. J Food Sci 2016; 81:M1184-91. [DOI: 10.1111/1750-3841.13295] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2015] [Revised: 03/01/2016] [Accepted: 03/07/2016] [Indexed: 11/30/2022]
Affiliation(s)
- Hui-Ling Hsiao
- Dept. of Food Science; National Ilan Univ; 1 Sec. 1, Shen Nung Rd. Ilan city Taiwan, R.O.C
| | - Shih-Bin Lin
- Dept. of Food Science; National Ilan Univ; 1 Sec. 1, Shen Nung Rd. Ilan city Taiwan, R.O.C
| | - Li-Chen Chen
- Dept. of Food Science; National Ilan Univ; 1 Sec. 1, Shen Nung Rd. Ilan city Taiwan, R.O.C
| | - Hui-Huang Chen
- Dept. of Food Science; National Ilan Univ; 1 Sec. 1, Shen Nung Rd. Ilan city Taiwan, R.O.C
| |
Collapse
|
7
|
Sulaeva I, Henniges U, Rosenau T, Potthast A. Bacterial cellulose as a material for wound treatment: Properties and modifications. A review. Biotechnol Adv 2015; 33:1547-71. [DOI: 10.1016/j.biotechadv.2015.07.009] [Citation(s) in RCA: 209] [Impact Index Per Article: 23.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2015] [Revised: 07/02/2015] [Accepted: 07/29/2015] [Indexed: 12/19/2022]
|